CinnaGen Reports Results Of ReciGen For COVID-19

Interferon Beta-1a In Combination Therapy For COVID-19 Pneumonia

 
• By Dean Rudge
Tehran
CinnaGen has also a nasal formulation of interferon beta 1a under investigation • Source: Shutterstock

More from Products

More from Generics Bulletin